A detailed history of Marsico Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Marsico Capital Management LLC holds 185,785 shares of LLY stock, worth $150 Million. This represents 5.24% of its overall portfolio holdings.

Number of Shares
185,785
Previous 198,791 6.54%
Holding current value
$150 Million
Previous $155 Million 8.76%
% of portfolio
5.24%
Previous 5.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $9.43 Million - $11.8 Million
-13,006 Reduced 6.54%
185,785 $168 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $2.67 Million - $3.57 Million
-4,509 Reduced 2.22%
198,791 $155 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $4.99 Million - $5.89 Million
-9,507 Reduced 4.47%
203,300 $119 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $1.04 Million - $1.43 Million
2,387 Added 1.13%
212,807 $114 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $2.06 Million - $2.75 Million
-5,867 Reduced 2.71%
210,420 $98.7 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $689,287 - $809,535
-2,219 Reduced 1.02%
216,287 $74.3 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $3.67 Million - $4.27 Million
11,406 Added 5.51%
218,506 $79.9 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $11.5 Million - $13.1 Million
-38,916 Reduced 15.82%
207,100 $67 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $68.6 Million - $80.5 Million
246,016 New
246,016 $79.8 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $27.1 Million - $31.7 Million
-244,995 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $6.22 Million - $7.32 Million
-55,901 Reduced 18.58%
244,995 $31.8 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $31.9 Million - $35.7 Million
300,896 New
300,896 $34.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Marsico Capital Management LLC Portfolio

Follow Marsico Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marsico Capital Management LLC with notifications on news.